By purchasing, you confirm you are 21 years of age or older and a qualified researcher
When used in topical formulations, the most commonly reported issues are localised and mild, and may include: Skin irritation or redness at the site of application Contact dermatitis in individuals with sensitive skin or known peptide sensitivities Scalp itching or tingling , which may be transient The following precautions are advised: Avoid application to broken, inflamed, or irritated skin , and keep the product away from the eyes and mucous membranes
Its supporting evidence is animal and cell-culture research, which is genuinely interesting for understanding mechanism but doesn't establish human safety or efficacy at any particular dose
Researchers should always verify product documentation and testing information before use
Notes: The weekly dose of 15mg should not be exceeded
Semaglutide (Wegovy ) Injectable (Commercial Product by Novo Nordisk) Semaglutide Injectable Description 1-3 Semaglutide, a synthetic glucagon-like peptide-1 receptor agonist (GLP-1 RA), is an incretin mimetic